Consolidated Portfolio Review Corp Thermo Fisher Scientific Inc. Transaction History
Consolidated Portfolio Review Corp
- $448 Billion
- Q3 2024
A detailed history of Consolidated Portfolio Review Corp transactions in Thermo Fisher Scientific Inc. stock. As of the latest transaction made, Consolidated Portfolio Review Corp holds 616 shares of TMO stock, worth $317,966. This represents 0.09% of its overall portfolio holdings.
Number of Shares
616
Previous 587
4.94%
Holding current value
$317,966
Previous $325 Million
17.38%
% of portfolio
0.09%
Previous 0.08%
Shares
7 transactions
Others Institutions Holding TMO
# of Institutions
2,836Shares Held
334MCall Options Held
2.37MPut Options Held
2.75M-
Vanguard Group Inc Valley Forge, PA33.1MShares$17.1 Billion0.37% of portfolio
-
Black Rock Inc. New York, NY29.5MShares$15.2 Billion0.38% of portfolio
-
State Street Corp Boston, MA16.3MShares$8.42 Billion0.42% of portfolio
-
Morgan Stanley New York, NY11.1MShares$5.75 Billion0.51% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD11MShares$5.66 Billion0.78% of portfolio
About THERMO FISHER SCIENTIFIC INC.
- Ticker TMO
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 391,788,992
- Market Cap $202B
- Description
- Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as di...